Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125652
Status:
RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-11-04
Brief Title:
Administration of Anti Tim-3CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia rrAML
Sponsor:
Xuzhou Medical University
Organization:
Xuzhou Medical University
Organization Data
Organization:
Xuzhou Medical University
Class:
OTHER
Study ID:
XYFY2023-KL358-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xuzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Kai Lin XuMD
Responsible Party Title:
President
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xuzhou Medical University
Old Name:
None
Old Organization:
None